Industry: Service & Software
Published Date: 2024-11-15
Pages: 98 Pages
Report ld: 3377892
Request Sample
Customized Report
Postbiotics CDMO Service Market Size(US$)

CAGR 2024-2030
9.3%
Market Size,2030
USD 168
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Postbiotics CDMO Service revenue was US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the review period (2024-2030).
In United States the Postbiotics CDMO Service revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Postbiotics CDMO Service market, also covers the segmentation data of other regions in regional level and county level.
Postbiotics are inactivated microorganisms and/or bacterial components with a clear genetic background that are beneficial to the health of the host, including or excluding products of their metabolites; chemically synthesized components and viruses/bacteriophages and their products are excluded. Postbiotic products are added with postbiotic ingredients and are widely used in different fields (feed, food health, personal care, pet nutrition, etc.).CDMOs (Contract Development and Manufacturing Organizations) provide professional R&D and production services to other companies to help them bring postbiotic products to market. These organizations usually have extensive R&D experience and production capabilities to meet the needs of different customers.
The global key players of Postbiotics CDMO Service include ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma, Sacco System, etc. The global five biggest players hold a share of % in 2023.
Global Postbiotics CDMO Service Scope and Market Size
Postbiotics CDMO Service market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Postbiotics CDMO Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Postbiotics CDMO Service market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Postbiotics CDMO Service definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Postbiotics CDMO Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Postbiotics CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Postbiotics CDMO Service revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Postbiotics CDMO Service Product Introduction
1.2 Global Postbiotics CDMO Service Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Postbiotics CDMO Service Market Size for the Year 2019-2030
1.2.2 United States Postbiotics CDMO Service Market Size for the Year 2019-2030
1.3 Postbiotics CDMO Service Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Postbiotics CDMO Service in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Postbiotics CDMO Service Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Postbiotics CDMO Service Market Dynamics
1.4.1 Postbiotics CDMO Service Industry Trends
1.4.2 Postbiotics CDMO Service Market Drivers
1.4.3 Postbiotics CDMO Service Market Challenges
1.4.4 Postbiotics CDMO Service Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Postbiotics CDMO Service by Type
2.1 Postbiotics CDMO Service Market by Type
2.1.1 Oral Dosage Forms (Capsules And Tablets)
2.1.2 Powders and Granules
2.1.3 Liquid Preparations
2.2 Global Postbiotics CDMO Service Market Size by Type (2019, 2023 & 2030)
2.3 Global Postbiotics CDMO Service Market Size by Type (2019-2030)
2.4 United States Postbiotics CDMO Service Market Size by Type (2019, 2023 & 2030)
2.5 United States Postbiotics CDMO Service Market Size by Type (2019-2030)
3 Postbiotics CDMO Service by Application
3.1 Postbiotics CDMO Service Market by Application
3.1.1 Medicines and Health Products
3.1.2 Food
3.1.3 Pet Food
3.1.4 Cosmetics
3.2 Global Postbiotics CDMO Service Market Size, by Application (2019, 2023 & 2030)
3.3 Global Postbiotics CDMO Service Market Size by Application (2019-2030)
3.4 United States Postbiotics CDMO Service Market Size by Application (2019, 2023 & 2030)
3.5 United States Postbiotics CDMO Service Market Size by Application (2019-2030)
4 Global Postbiotics CDMO Service Competitor Landscape by Company
4.1 Global Postbiotics CDMO Service Market Size by Company
4.1.1 Global Key Companies of Postbiotics CDMO Service, Ranked by Revenue (2023)
4.1.2 Global Postbiotics CDMO Service Revenue by Player (2019-2024)
4.2 Global Postbiotics CDMO Service Concentration Ratio (CR)
4.2.1 Postbiotics CDMO Service Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Postbiotics CDMO Service in 2023
4.2.3 Global Postbiotics CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Postbiotics CDMO Service Head office and Area Served
4.4 Global Key Players of Postbiotics CDMO Service, Product and Application
4.5 Global Key Players of Postbiotics CDMO Service, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Postbiotics CDMO Service Market Size by Company
4.7.1 Key Players of Postbiotics CDMO Service in United States, Ranked by Revenue (2023)
4.7.2 United States Postbiotics CDMO Service Revenue by Players (2022, 2023 & 2024)
5 Global Postbiotics CDMO Service Market Size by Region
5.1 Global Postbiotics CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Postbiotics CDMO Service Market Size by Region (2019-2030)
5.2.1 Global Postbiotics CDMO Service Market Size by Region: 2019-2024
5.2.2 Global Postbiotics CDMO Service Market Size by Region: 2025-2030
6 Americas
6.1 Americas Postbiotics CDMO Service Market Size YoY Growth 2019-2030
6.2 Americas Postbiotics CDMO Service Market Size by Type
6.2.1 Americas Postbiotics CDMO Service Market Size by Type (2019-2024)
6.2.2 Americas Postbiotics CDMO Service Market Size by Type (2025-2030)
6.2.3 Americas Postbiotics CDMO Service Market Share by Type (2019-2030)
6.3 Americas Postbiotics CDMO Service Market Size by Application
6.3.1 Americas Postbiotics CDMO Service Market Size by Application (2019-2024)
6.3.2 Americas Postbiotics CDMO Service Market Size by Application (2025-2030)
6.3.3 Americas Postbiotics CDMO Service Market Share by Application (2019-2030)
6.4 Americas Postbiotics CDMO Service Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Postbiotics CDMO Service Market Size YoY Growth 2019-2030
7.2 EMEA Postbiotics CDMO Service Market Size by Type
7.2.1 EMEA Postbiotics CDMO Service Market Size by Type (2019-2024)
7.2.2 EMEA Postbiotics CDMO Service Market Size by Type (2025-2030)
7.2.3 EMEA Postbiotics CDMO Service Market Share by Type (2019-2030)
7.3 EMEA Postbiotics CDMO Service Market Size by Application
7.3.1 EMEA Postbiotics CDMO Service Market Size by Application (2019-2024)
7.3.2 EMEA Postbiotics CDMO Service Market Size by Application (2025-2030)
7.3.3 EMEA Postbiotics CDMO Service Market Share by Application (2019-2030)
7.4 EMEA Postbiotics CDMO Service Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Postbiotics CDMO Service Market Size by Type
8.1.1 China Postbiotics CDMO Service Market Size by Type (2019-2024)
8.1.2 China Postbiotics CDMO Service Market Size by Type (2025-2030)
8.1.3 China Postbiotics CDMO Service Market Share by Type (2019-2030)
8.2 China Postbiotics CDMO Service Market Size by Application
8.2.1 China Postbiotics CDMO Service Market Size by Application (2019-2024)
8.2.2 China Postbiotics CDMO Service Market Size by Application (2025-2030)
8.2.3 China Postbiotics CDMO Service Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Postbiotics CDMO Service Market Size YoY Growth 2019-2030
9.2 APAC Postbiotics CDMO Service Market Size by Type
9.2.1 APAC Postbiotics CDMO Service Market Size by Type (2019-2024)
9.2.2 APAC Postbiotics CDMO Service Market Size by Type (2025-2030)
9.2.3 APAC Postbiotics CDMO Service Market Share by Type (2019-2030)
9.3 APAC Postbiotics CDMO Service Market Size by Application
9.3.1 APAC Postbiotics CDMO Service Market Size by Application (2019-2024)
9.3.2 APAC Postbiotics CDMO Service Market Size by Application (2025-2030)
9.3.3 APAC Postbiotics CDMO Service Market Share by Application (2019-2030)
9.4 APAC Postbiotics CDMO Service Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 ILDONG Bioscience Co., Ltd.
10.1.1 ILDONG Bioscience Co., Ltd. Company Details
10.1.2 ILDONG Bioscience Co., Ltd. Business Overview
10.1.3 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Introduction
10.1.4 ILDONG Bioscience Co., Ltd. Revenue in Postbiotics CDMO Service Business (2019-2024)
10.1.5 ILDONG Bioscience Co., Ltd. Recent Development
10.2 Bioprox Healthcare
10.2.1 Bioprox Healthcare Company Details
10.2.2 Bioprox Healthcare Business Overview
10.2.3 Bioprox Healthcare Postbiotics CDMO Service Introduction
10.2.4 Bioprox Healthcare Revenue in Postbiotics CDMO Service Business (2019-2024)
10.2.5 Bioprox Healthcare Recent Development
10.3 Exden
10.3.1 Exden Company Details
10.3.2 Exden Business Overview
10.3.3 Exden Postbiotics CDMO Service Introduction
10.3.4 Exden Revenue in Postbiotics CDMO Service Business (2019-2024)
10.3.5 Exden Recent Development
10.4 JuneYao Group (BioGrowing)
10.4.1 JuneYao Group (BioGrowing) Company Details
10.4.2 JuneYao Group (BioGrowing) Business Overview
10.4.3 JuneYao Group (BioGrowing) Postbiotics CDMO Service Introduction
10.4.4 JuneYao Group (BioGrowing) Revenue in Postbiotics CDMO Service Business (2019-2024)
10.4.5 JuneYao Group (BioGrowing) Recent Development
10.5 dsm-firmenich (Adare Pharma Solutions)
10.5.1 dsm-firmenich (Adare Pharma Solutions) Company Details
10.5.2 dsm-firmenich (Adare Pharma Solutions) Business Overview
10.5.3 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Introduction
10.5.4 dsm-firmenich (Adare Pharma Solutions) Revenue in Postbiotics CDMO Service Business (2019-2024)
10.5.5 dsm-firmenich (Adare Pharma Solutions) Recent Development
10.6 Sirio Pharma
10.6.1 Sirio Pharma Company Details
10.6.2 Sirio Pharma Business Overview
10.6.3 Sirio Pharma Postbiotics CDMO Service Introduction
10.6.4 Sirio Pharma Revenue in Postbiotics CDMO Service Business (2019-2024)
10.6.5 Sirio Pharma Recent Development
10.7 Sacco System
10.7.1 Sacco System Company Details
10.7.2 Sacco System Business Overview
10.7.3 Sacco System Postbiotics CDMO Service Introduction
10.7.4 Sacco System Revenue in Postbiotics CDMO Service Business (2019-2024)
10.7.5 Sacco System Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Postbiotics CDMO Service market is projected to grow from US$ 107 million in 2025 to US$ 198 million by 2032, at a CAGR of 9.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 118
USD 4900.00
(Single User License)
The global Postbiotics CDMO Service market size was US$ 107 million in 2025 and is forecast to reach a readjusted size of US$ 198 million by 2032 with a CAGR of 9.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 76
USD 4250.00
(Single User License)
The global Postbiotics CDMO Service market was valued at US$ 107 million in 2025 and is anticipated to reach US$ 198 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 110
USD 2900.00
(Single User License)
The global market for Postbiotics CDMO Service was estimated to be worth US$ 107 million in 2025 and is projected to reach US$ 198 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 94
USD 3950.00
(Single User License)
The global Postbiotics CDMO Service market size was US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 182 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 123
USD 4900.00
(Single User License)
The global market for Postbiotics CDMO Service was estimated to be worth US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 89
USD 3950.00
(Single User License)
The global market for Postbiotics CDMO Service was valued at US$ 99 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published Date: 2025-03-12
Pages: 77
USD 2900.00
(Single User License)
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 168 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
Published Date: 2024-11-15
Pages: 130
USD 4900.00
(Single User License)
The global market for Postbiotics CDMO Service was estimated to be worth US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 99
USD 3950.00
(Single User License)
The global Postbiotics CDMO Service market is projected to grow from US$ 107 million in 2025 to US$ 198 million by 2032, at a CAGR of 9.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 118
The global Postbiotics CDMO Service market size was US$ 107 million in 2025 and is forecast to reach a readjusted size of US$ 198 million by 2032 with a CAGR of 9.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 76
The global Postbiotics CDMO Service market was valued at US$ 107 million in 2025 and is anticipated to reach US$ 198 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 110
The global market for Postbiotics CDMO Service was estimated to be worth US$ 107 million in 2025 and is projected to reach US$ 198 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 94
The global Postbiotics CDMO Service market size was US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 182 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 123
The global market for Postbiotics CDMO Service was estimated to be worth US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 89
The global market for Postbiotics CDMO Service was valued at US$ 99 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published: 2025-03-12
Pages: 77
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 168 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
Published: 2024-11-15
Pages: 130
The global market for Postbiotics CDMO Service was estimated to be worth US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now